BHST
BioHarvest Sciences Inc. Common Stock
2.91
5 x 4.03
1 x 2.93
bid
ask
+
0.00
0.00%
04:00 PM
timesize
| Ytd | -43.93% | |
| 1y | -57.33% |
2.90
day range
2.98
2.75
52 week range
12.80
| Open | 2.90 | Prev Close | 2.91 | Low | 2.90 | High | 2.98 | Mkt Cap | 65.96M |
| Vol | 6.00 | Avg Vol | 30.28K | EPS | -0.58 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.49 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 3.67 | 200-d Avg | 5.78 | 1yr Est | 14.67 |
| Income Statement | |||
| Total Revenue | 8.51M | ||
| Revenues (USD) | 8.51M | ||
| Cost of Revenue | 3.47M | ||
| Gross Profit | 5.04M | ||
| Operating Expenses | 6.87M | ||
| Research and Development Expense | 1.39M | ||
| Selling, General and Administrative Expense | 5.48M | ||
| Operating Income | -1.83M | ||
| Interest Expense | 875.00K | ||
| Income Tax Expense | 46.00K | ||
| Net Income | -2.64M | ||
| Net Income Common Stock | -2.64M | ||
| Net Income Common Stock (USD) | -2.64M | ||
| Consolidated Income | -2.64M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -1.72M | ||
| Earning Before Interest & Taxes (USD) | -1.72M | ||
| Weighted Average Shares | 22.67M | ||
| Weighted Average Shares Diluted | 22.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 20.17M | ||
| Cash and Equivalents (USD) | 20.17M | ||
| Investments | 436.00K | ||
| Investments Non-Current | 436.00K | ||
| Trade and Non-Trade Receivables | 3.18M | ||
| Current Assets | 28.32M | ||
| Property, Plant & Equipment Net | 16.80M | ||
| Total Assets | 45.56M | ||
| Debt Current | 3.00M | ||
| Total Debt | 14.04M | ||
| Current Liabilities | 9.58M | ||
| Debt Non-Current | 11.04M | ||
| Total Liabilities | 22.54M | ||
| Accumulated Retained Earnings (Deficit) | -110.19M | ||
| Shareholders Equity | 23.02M | ||
| Shareholders Equity (USD) | 23.02M | ||
| Assets Non-Current | 17.24M | ||
| Total Debt (USD) | 14.04M | ||
| Deferred Revenue | 474.00K | ||
| Inventory | 4.97M | ||
| Liabilities Non-Current | 12.96M | ||
| Trade and Non-Trade Payables | 5.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 428.00K | ||
| Net Cash Flow from Financing | -840.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.81M | ||
| Capital Expenditure | -593.00K | ||
| Issuance (Repayment) of Debt Securities | -810.00K | ||
| Net Cash Flow from Investing | -1.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1000.00K | ||
| Net Cash Flow from Operations | -1.38M | ||
| Effect of Exchange Rate Changes on Cash | -46.00K | ||
| Share Based Compensation | 216.00K | ||